Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatectomy | 12 | 2022 | 1841 | 1.080 |
Why?
|
| Transurethral Resection of Prostate | 2 | 2024 | 81 | 1.040 |
Why?
|
| Urology | 4 | 2024 | 411 | 0.970 |
Why?
|
| Prostatic Hyperplasia | 3 | 2024 | 523 | 0.900 |
Why?
|
| Urologic Surgical Procedures | 3 | 2019 | 299 | 0.820 |
Why?
|
| Lasers, Solid-State | 1 | 2024 | 183 | 0.770 |
Why?
|
| Kidney Calices | 2 | 2011 | 26 | 0.670 |
Why?
|
| Prostatic Neoplasms | 18 | 2023 | 11230 | 0.620 |
Why?
|
| Laparoscopy | 10 | 2019 | 2055 | 0.610 |
Why?
|
| Robotics | 5 | 2014 | 826 | 0.570 |
Why?
|
| Laser Therapy | 1 | 2024 | 1110 | 0.550 |
Why?
|
| Kidney Calculi | 3 | 2017 | 469 | 0.520 |
Why?
|
| Nephrostomy, Percutaneous | 2 | 2017 | 79 | 0.500 |
Why?
|
| Carcinoma, Transitional Cell | 4 | 2023 | 799 | 0.500 |
Why?
|
| Urinary Bladder Neoplasms | 6 | 2023 | 2251 | 0.450 |
Why?
|
| Nephrectomy | 7 | 2015 | 949 | 0.450 |
Why?
|
| Penile Neoplasms | 2 | 2021 | 158 | 0.420 |
Why?
|
| Prostate | 7 | 2024 | 1781 | 0.400 |
Why?
|
| Urinary Calculi | 1 | 2011 | 90 | 0.370 |
Why?
|
| Varicocele | 1 | 2011 | 75 | 0.370 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 643 | 0.350 |
Why?
|
| Electrocoagulation | 1 | 2011 | 157 | 0.350 |
Why?
|
| Urine | 1 | 2011 | 362 | 0.340 |
Why?
|
| Diverticulum | 1 | 2011 | 137 | 0.340 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2011 | 182 | 0.330 |
Why?
|
| Medicine | 1 | 2017 | 947 | 0.320 |
Why?
|
| Ureter | 2 | 2012 | 370 | 0.320 |
Why?
|
| Clinical Competence | 4 | 2019 | 4860 | 0.320 |
Why?
|
| Blood Transfusion | 2 | 2017 | 1309 | 0.320 |
Why?
|
| Nomograms | 1 | 2010 | 236 | 0.310 |
Why?
|
| Ablation Techniques | 1 | 2011 | 255 | 0.300 |
Why?
|
| Testis | 1 | 2011 | 784 | 0.300 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2007 | 79 | 0.280 |
Why?
|
| Computer Simulation | 2 | 2019 | 6291 | 0.270 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2011 | 621 | 0.260 |
Why?
|
| Kidney Neoplasms | 8 | 2015 | 4300 | 0.250 |
Why?
|
| Prostate-Specific Antigen | 7 | 2022 | 2487 | 0.250 |
Why?
|
| Ureteral Obstruction | 1 | 2007 | 297 | 0.250 |
Why?
|
| Endoscopy | 3 | 2024 | 1862 | 0.240 |
Why?
|
| Internship and Residency | 5 | 2024 | 5956 | 0.240 |
Why?
|
| Holmium | 1 | 2024 | 29 | 0.230 |
Why?
|
| Cryosurgery | 3 | 2015 | 477 | 0.230 |
Why?
|
| Neoplasm Recurrence, Local | 8 | 2015 | 9442 | 0.220 |
Why?
|
| Cystectomy | 5 | 2023 | 645 | 0.200 |
Why?
|
| Incidental Findings | 1 | 2007 | 697 | 0.190 |
Why?
|
| Urinary Bladder | 5 | 2023 | 1162 | 0.190 |
Why?
|
| Neurilemmoma | 1 | 2007 | 524 | 0.190 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2007 | 735 | 0.190 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2022 | 195 | 0.180 |
Why?
|
| Male | 47 | 2024 | 365203 | 0.160 |
Why?
|
| Treatment Outcome | 15 | 2024 | 65480 | 0.160 |
Why?
|
| Lymphatic Metastasis | 3 | 2022 | 2916 | 0.150 |
Why?
|
| Postoperative Complications | 6 | 2017 | 15889 | 0.150 |
Why?
|
| Suture Techniques | 2 | 2014 | 779 | 0.150 |
Why?
|
| Biopsy | 4 | 2023 | 6805 | 0.130 |
Why?
|
| Nephrons | 2 | 2014 | 168 | 0.130 |
Why?
|
| Perioperative Period | 1 | 2017 | 252 | 0.130 |
Why?
|
| Humans | 54 | 2024 | 768970 | 0.120 |
Why?
|
| Cadaver | 1 | 2019 | 1366 | 0.120 |
Why?
|
| Teaching Rounds | 1 | 2019 | 282 | 0.120 |
Why?
|
| Urinary Catheterization | 2 | 2014 | 195 | 0.120 |
Why?
|
| Hospital Costs | 2 | 2017 | 959 | 0.120 |
Why?
|
| Middle Aged | 31 | 2021 | 223737 | 0.120 |
Why?
|
| Retrospective Studies | 18 | 2024 | 81903 | 0.120 |
Why?
|
| Aged | 27 | 2021 | 171786 | 0.110 |
Why?
|
| Disease-Free Survival | 4 | 2012 | 6856 | 0.110 |
Why?
|
| Neoplasm Staging | 5 | 2023 | 11262 | 0.110 |
Why?
|
| Lymph Node Excision | 3 | 2022 | 1273 | 0.110 |
Why?
|
| Time Factors | 10 | 2015 | 40261 | 0.110 |
Why?
|
| Brachytherapy | 1 | 2021 | 1224 | 0.110 |
Why?
|
| Hematocrit | 1 | 2014 | 623 | 0.110 |
Why?
|
| Calculi | 1 | 2013 | 48 | 0.110 |
Why?
|
| Kidney | 3 | 2014 | 7058 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2019 | 1260 | 0.100 |
Why?
|
| Databases, Factual | 3 | 2017 | 8094 | 0.100 |
Why?
|
| Salvage Therapy | 2 | 2022 | 1277 | 0.100 |
Why?
|
| Ureteroscopes | 1 | 2012 | 22 | 0.100 |
Why?
|
| Circumcision, Male | 1 | 2013 | 148 | 0.100 |
Why?
|
| Logistic Models | 4 | 2017 | 13318 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2007 | 4064 | 0.100 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 1006 | 0.100 |
Why?
|
| Competency-Based Education | 1 | 2013 | 226 | 0.100 |
Why?
|
| Electrosurgery | 1 | 2011 | 53 | 0.090 |
Why?
|
| Blood Coagulation Disorders | 1 | 2014 | 350 | 0.090 |
Why?
|
| Ergocalciferols | 1 | 2012 | 110 | 0.090 |
Why?
|
| Urologic Neoplasms | 1 | 2014 | 318 | 0.090 |
Why?
|
| Lithotripsy | 1 | 2011 | 141 | 0.090 |
Why?
|
| Intraoperative Period | 1 | 2011 | 513 | 0.090 |
Why?
|
| Work Schedule Tolerance | 1 | 2014 | 553 | 0.090 |
Why?
|
| Gels | 1 | 2011 | 423 | 0.090 |
Why?
|
| Kidney Pelvis | 1 | 2011 | 195 | 0.090 |
Why?
|
| Disease Progression | 3 | 2011 | 13674 | 0.090 |
Why?
|
| Computer-Assisted Instruction | 1 | 2013 | 366 | 0.090 |
Why?
|
| Lacerations | 1 | 2012 | 150 | 0.090 |
Why?
|
| Sus scrofa | 1 | 2011 | 430 | 0.090 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2014 | 2297 | 0.090 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2011 | 3200 | 0.090 |
Why?
|
| Kidney Cortex | 1 | 2009 | 168 | 0.080 |
Why?
|
| Urography | 1 | 2011 | 316 | 0.080 |
Why?
|
| Learning Curve | 1 | 2011 | 232 | 0.080 |
Why?
|
| Tissue Kallikreins | 1 | 2009 | 14 | 0.080 |
Why?
|
| Psychomotor Performance | 2 | 2014 | 1894 | 0.080 |
Why?
|
| Preoperative Period | 1 | 2011 | 565 | 0.080 |
Why?
|
| Organ Size | 2 | 2011 | 2268 | 0.080 |
Why?
|
| Endpoint Determination | 1 | 2011 | 594 | 0.080 |
Why?
|
| Electrodes | 1 | 2011 | 617 | 0.080 |
Why?
|
| Odds Ratio | 3 | 2017 | 9684 | 0.080 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 1176 | 0.080 |
Why?
|
| User-Computer Interface | 1 | 2014 | 1406 | 0.070 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 1500 | 0.070 |
Why?
|
| Fatigue | 1 | 2014 | 1557 | 0.070 |
Why?
|
| Adult | 18 | 2022 | 223851 | 0.070 |
Why?
|
| Dyspnea | 1 | 2014 | 1352 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 1680 | 0.070 |
Why?
|
| Aged, 80 and over | 11 | 2015 | 59739 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 3 | 2022 | 3629 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 4076 | 0.070 |
Why?
|
| SEER Program | 1 | 2011 | 1473 | 0.070 |
Why?
|
| Prognosis | 6 | 2012 | 30046 | 0.070 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 1328 | 0.060 |
Why?
|
| Biopsy, Needle | 2 | 2007 | 1626 | 0.060 |
Why?
|
| Ultrasonography, Doppler | 1 | 2007 | 463 | 0.060 |
Why?
|
| United States | 8 | 2021 | 73186 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 12095 | 0.060 |
Why?
|
| Vitamins | 1 | 2012 | 1638 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2014 | 3586 | 0.050 |
Why?
|
| Female | 22 | 2022 | 397515 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2014 | 1767 | 0.050 |
Why?
|
| Foreign Medical Graduates | 1 | 2024 | 77 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2011 | 1045 | 0.050 |
Why?
|
| General Surgery | 1 | 2014 | 1722 | 0.050 |
Why?
|
| Nitrous Oxide | 1 | 2023 | 166 | 0.050 |
Why?
|
| Administration, Intravesical | 1 | 2022 | 92 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2009 | 1091 | 0.050 |
Why?
|
| Survival Rate | 4 | 2012 | 12873 | 0.050 |
Why?
|
| Ischemia | 1 | 2011 | 1900 | 0.050 |
Why?
|
| Endosonography | 1 | 2007 | 626 | 0.050 |
Why?
|
| Education, Medical | 1 | 2014 | 1742 | 0.050 |
Why?
|
| Vitamin D Deficiency | 1 | 2012 | 1388 | 0.050 |
Why?
|
| Achievement | 1 | 2024 | 288 | 0.050 |
Why?
|
| Prevalence | 3 | 2022 | 15879 | 0.050 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2003 | 141 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2012 | 39394 | 0.050 |
Why?
|
| Forecasting | 1 | 2010 | 2945 | 0.050 |
Why?
|
| Venous Thromboembolism | 1 | 2014 | 1881 | 0.050 |
Why?
|
| Inguinal Canal | 1 | 2021 | 71 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2009 | 2492 | 0.040 |
Why?
|
| Curriculum | 1 | 2014 | 3782 | 0.040 |
Why?
|
| Lidocaine | 1 | 2023 | 546 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2022 | 383 | 0.040 |
Why?
|
| Prospective Studies | 6 | 2023 | 54962 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 3 | 2014 | 2228 | 0.040 |
Why?
|
| Incidence | 5 | 2021 | 21547 | 0.040 |
Why?
|
| Calcium | 1 | 2012 | 5792 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2003 | 702 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2011 | 6002 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2014 | 3838 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2022 | 999 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2022 | 1793 | 0.040 |
Why?
|
| Muscles | 1 | 2022 | 1582 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2021 | 498 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 2023 | 1005 | 0.030 |
Why?
|
| Ureteral Calculi | 1 | 2017 | 117 | 0.030 |
Why?
|
| Tumor Burden | 2 | 2014 | 1913 | 0.030 |
Why?
|
| Preoperative Care | 3 | 2011 | 2258 | 0.030 |
Why?
|
| Predictive Value of Tests | 5 | 2011 | 15471 | 0.030 |
Why?
|
| Models, Biological | 1 | 2011 | 9499 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2022 | 1524 | 0.030 |
Why?
|
| Codeine | 1 | 2014 | 52 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 2862 | 0.030 |
Why?
|
| Urinary Bladder Calculi | 1 | 2013 | 12 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2022 | 1421 | 0.030 |
Why?
|
| Area Under Curve | 2 | 2009 | 1645 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2022 | 3554 | 0.030 |
Why?
|
| Risk Factors | 7 | 2015 | 74976 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 8664 | 0.030 |
Why?
|
| Cystitis | 1 | 2013 | 96 | 0.030 |
Why?
|
| Adolescent | 2 | 2011 | 89244 | 0.030 |
Why?
|
| Hematuria | 1 | 2013 | 233 | 0.020 |
Why?
|
| Oxygen | 1 | 2023 | 4272 | 0.020 |
Why?
|
| Constriction | 1 | 2011 | 168 | 0.020 |
Why?
|
| Swine | 2 | 2012 | 5997 | 0.020 |
Why?
|
| Cautery | 1 | 2011 | 73 | 0.020 |
Why?
|
| Young Adult | 3 | 2014 | 60131 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2003 | 2593 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2022 | 3473 | 0.020 |
Why?
|
| Motivation | 1 | 2021 | 2025 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2013 | 386 | 0.020 |
Why?
|
| Age Factors | 3 | 2015 | 18435 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 2909 | 0.020 |
Why?
|
| Acetaminophen | 1 | 2014 | 556 | 0.020 |
Why?
|
| Feedback | 1 | 2013 | 799 | 0.020 |
Why?
|
| Sex Factors | 2 | 2015 | 10633 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2023 | 12467 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2011 | 584 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2021 | 24333 | 0.020 |
Why?
|
| alpha-Amylases | 1 | 1989 | 39 | 0.020 |
Why?
|
| Hand | 1 | 2014 | 913 | 0.020 |
Why?
|
| Pain | 1 | 2023 | 5100 | 0.020 |
Why?
|
| Sesquiterpenes | 1 | 2009 | 177 | 0.020 |
Why?
|
| Catheterization | 1 | 2014 | 1431 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2009 | 253 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 5804 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2011 | 8748 | 0.020 |
Why?
|
| Reference Values | 1 | 2015 | 4940 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2011 | 771 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2017 | 6346 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2014 | 2089 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2014 | 1070 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 36854 | 0.020 |
Why?
|
| Necrosis | 1 | 2011 | 1620 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2011 | 795 | 0.020 |
Why?
|
| Sodium | 1 | 2012 | 1597 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2013 | 1506 | 0.020 |
Why?
|
| Checklist | 1 | 2013 | 841 | 0.020 |
Why?
|
| Obesity | 1 | 2008 | 13091 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 2012 | 1803 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 8055 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 2122 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2011 | 1481 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 2716 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2009 | 1714 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2017 | 3270 | 0.010 |
Why?
|
| Saliva | 1 | 1989 | 854 | 0.010 |
Why?
|
| Hospitals | 1 | 2017 | 3904 | 0.010 |
Why?
|
| Autopsy | 1 | 2007 | 1013 | 0.010 |
Why?
|
| Length of Stay | 1 | 2017 | 6526 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2011 | 41808 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2009 | 3631 | 0.010 |
Why?
|
| Reoperation | 1 | 2013 | 4342 | 0.010 |
Why?
|
| Child | 1 | 2011 | 80960 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10592 | 0.010 |
Why?
|
| Fasting | 1 | 1989 | 1610 | 0.010 |
Why?
|
| Period Circadian Proteins | 1 | 2003 | 97 | 0.010 |
Why?
|
| Medicare | 1 | 2021 | 6888 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2008 | 2664 | 0.010 |
Why?
|
| Linear Models | 1 | 2012 | 5891 | 0.010 |
Why?
|
| Body Composition | 1 | 2011 | 2462 | 0.010 |
Why?
|
| Probability | 1 | 2007 | 2483 | 0.010 |
Why?
|
| Neurosecretory Systems | 1 | 2003 | 223 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2015 | 5369 | 0.010 |
Why?
|
| ROC Curve | 1 | 2009 | 3629 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2009 | 3621 | 0.010 |
Why?
|
| Animals | 5 | 2012 | 169335 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4926 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 839 | 0.010 |
Why?
|
| Transgenes | 1 | 2003 | 1016 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 7861 | 0.010 |
Why?
|
| Vitamin D | 1 | 2012 | 3311 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 5801 | 0.010 |
Why?
|
| Hospitalization | 1 | 2017 | 10847 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 2067 | 0.010 |
Why?
|
| Glucose | 1 | 1989 | 4352 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 20245 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 1973 | 0.010 |
Why?
|
| Registries | 1 | 2011 | 8384 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10486 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2013 | 26428 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 17173 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14752 | 0.010 |
Why?
|
| Research Design | 1 | 2007 | 6214 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2003 | 3450 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 22296 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2008 | 13055 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 15951 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1989 | 5892 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2003 | 9565 | 0.010 |
Why?
|
| Mice | 2 | 2009 | 82072 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 11116 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2003 | 12806 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 13698 | 0.000 |
Why?
|
| Glucose Tolerance Test | 1 | 1989 | 1183 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 11932 | 0.000 |
Why?
|
| Neurons | 1 | 2003 | 9519 | 0.000 |
Why?
|
Concepts
(274)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_